Biocon Biologics: Arrangements for new loan to repay old debt, possibility of IPO under consideration.

Biocon Biologics debt: Biocon subsidiary Biocon Biologics on Thursday said it has raised fresh debt to repay $1.1 billion (Rs 9,300 crore) long-term debt through US dollar bonds and a new syndicated facility. In this, 80 (…) payable by the year 2029 at a coupon of 6.67 percent.

Leave a Reply

Your email address will not be published. Required fields are marked *

Optimized by Optimole